Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
Clinical trial NCT03999996 · COMPLETED
Trial details
- NCT number
- NCT03999996
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2024-05-25
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.